美中嘉和(02453.HK):上海信荷將不再是公司控股股東的成員
格隆匯6月25日丨美中嘉和(02453.HK)發佈公告,2025年6月24日,公司獲上海信荷(持有公司約1333.33萬股內資股股份)通知,其於2025年6月24日召開的合夥人會議審議並批準,爲了進一步優化上海信荷的經營決策方式,上海醫學之星將不再爲上海信荷的有限合夥人,且楊博士最終控制的上海信復企業管理中心(有限合夥)將不再爲上海信荷的普通合夥人。變更後上海信荷的各合夥人均獨立於楊博士及其控制的實體及彼等的關連人士。
因此,上海信荷將不再是公司控股股東的成員。於本公告日期,楊博士及其控制的實體,包括Morgancreek Investment Holdings Limited、 Concord Medical、Ascendium Group Limited、上海卉馥科技發展有限公司、泰和誠醫院管理集團有限公司、上海醫學之星、天津泰和誠及北京泰和誠,仍於約1.92億股內資股及6385.91萬股H股擁有權益,佔公司已發行股本總額及公司已發行股份於股東大會上的投票權的34.85%,並仍爲公司的控股股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.